MAPK3 and colorectal carcinoma: Studies of multiple CRC cell lines demonstrated that beta blockade inhibits cell viability and proliferation in a dose-dependent manner, probably through EGFR-Akt/ERK1/2 pathway, cell cycle arrest and apoptosis followed by suppression of β2 signaling (Coelho et al., 2015; Chin et al., 2016).